Previous close | 227.95 |
Open | 231.95 |
Bid | 230.95 x N/A |
Ask | 231.40 x N/A |
Day's range | 228.55 - 231.95 |
52-week range | 172.40 - 240.95 |
Volume | |
Avg. volume | 545 |
Market cap | 172.763B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 45.44 |
EPS (TTM) | 5.08 |
Earnings date | 23 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 1.01 (0.44%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
Key Insights Danaher to hold its Annual General Meeting on 7th of May CEO Rainer Blair's total compensation includes...
Senior Vice President - General Counsel Brian Ellis has sold 4,000 shares of Danaher Corp (NYSE:DHR) on April 24, 2024, according to a recent SEC Filing.